AAAAAA
Results: 1-25/27
Authors:
Schiffer, CA
Citation: Ca. Schiffer, Editorial overview - Leukemia, CURR OPIN O, 13(1), 2001, pp. 1-2
Authors:
Schiffer, CA
Citation: Ca. Schiffer, Management of patients refractory to platelet transfusion, LEUKEMIA, 15(4), 2001, pp. 683-685
Authors:
Schiffer, CA
Anderson, KC
Bennett, CL
Bernstein, S
Elting, LS
Goldsmith, M
Goldstein, M
Hume, H
McCullough, JJ
McIntyre, RE
Powell, BL
Rainey, JM
Rowley, SD
Rebulla, P
Troner, MB
Wagnon, AH
Citation: Ca. Schiffer et al., Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(5), 2001, pp. 1519-1538
Authors:
Lee, EJ
Petroni, GR
Schiffer, CA
Freter, CE
Johnson, JL
Barcos, M
Frizzera, G
Bloomfield, CD
Peterson, BA
Citation: Ej. Lee et al., Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251, J CL ONCOL, 19(20), 2001, pp. 4014-4022
Authors:
Morrison, VA
Rai, KR
Peterson, BL
Kolitz, JE
Elias, L
Appelbaum, FR
Hines, JD
Shepherd, L
Martell, RE
Larson, RA
Schiffer, CA
Citation: Va. Morrison et al., Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011, J CL ONCOL, 19(16), 2001, pp. 3611-3621
Authors:
Schiffer, CA
Citation: Ca. Schiffer, Acute myeloid leukemia in adults: where do we go from here?, CANC CHEMOT, 48, 2001, pp. S45-S52
Authors:
Schiffer, CA
Citation: Ca. Schiffer, Treatment of high-grade lymphoid malignancies in adults, SEM HEMATOL, 38(4), 2001, pp. 22-26
Authors:
Cheson, BD
Bennett, JM
Kantarjian, H
Schiffer, CA
Nimer, SD
Lowenberg, B
Stone, RM
Mittelman, M
Sanz, GF
Wijermans, PW
Greenberg, PL
Citation: Bd. Cheson et al., Response: Myelodysplastic syndromes standardized response criteria: further definition, BLOOD, 98(6), 2001, pp. 1985-1985
Authors:
Stone, RM
Berg, DT
George, SL
Dodge, RK
Paciucci, PA
Schulman, PP
Lee, EJ
Moore, JO
Powell, BL
Baer, MR
Bloomfield, CD
Schiffer, CA
Citation: Rm. Stone et al., Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine, BLOOD, 98(3), 2001, pp. 548-553
Authors:
Baer, MR
Stewart, GC
Dodge, RK
Leget, G
Sule, N
Mrozek, K
Schiffer, CA
Powel, BL
Kolitz, JE
Moore, JO
Stone, RM
Davey, FR
Carrol, AJ
Larson, RA
Bloomfield, CD
Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580
Authors:
Tallman, MS
Andersen, JW
Schiffer, CA
Appelbaum, FR
Feusner, JH
Ogden, A
Shepherd, L
Willman, C
Bloomfield, CD
Rowe, JM
Wiernik, PH
Citation: Ms. Tallman et al., All-trans-retinoic acid maintenance for acute promyelocytic leukemia, HEMAT BLOOD, 40, 2001, pp. 565-569
Authors:
Schiffer, CA
Citation: Ca. Schiffer, Leukemia, CURR OPIN O, 12(1), 2000, pp. 1-2
Authors:
Scott, WRP
Schiffer, CA
Citation: Wrp. Scott et Ca. Schiffer, Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance, STRUCTURE, 8(12), 2000, pp. 1259-1265
Authors:
Hensley, ML
Peterson, B
Silver, RT
Larson, RA
Schiffer, CA
Szatrowski, TP
Citation: Ml. Hensley et al., Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: Analysis of cancer and leukemia Group B 9013, J CL ONCOL, 18(6), 2000, pp. 1301-1308
Authors:
Ozer, H
Armitage, JO
Bennett, CL
Crawford, J
Demetri, GD
Pizzo, PA
Schiffer, CA
Smith, TJ
Somlo, G
Wade, JC
Wade, JL
Winn, RJ
Wozniak, AJ
Somerfield, MR
Citation: H. Ozer et al., 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines, J CL ONCOL, 18(20), 2000, pp. 3558-3585
Authors:
Rai, KR
Peterson, BL
Appelbaum, FR
Kolitz, J
Elias, L
Shepherd, L
Hines, J
Threatte, GA
Larson, RA
Cheson, BD
Schiffer, CA
Citation: Kr. Rai et al., Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia., N ENG J MED, 343(24), 2000, pp. 1750-1757
Authors:
Prabu-Jeyabalan, M
Nalivaika, E
Schiffer, CA
Citation: M. Prabu-jeyabalan et al., How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease, J MOL BIOL, 301(5), 2000, pp. 1207-1220
Authors:
Cheson, BD
Bennett, JM
Kantarjian, H
Pinto, A
Schiffer, CA
Nimer, SD
Lowenberg, B
Beran, M
de Witte, TM
Stone, RM
Mittelman, M
Sanz, GF
Wijermans, PW
Gore, S
Greenberg, PL
Citation: Bd. Cheson et al., Report of an international working group to standardize response criteria for myelodysplastic syndromes, BLOOD, 96(12), 2000, pp. 3671-3674
Authors:
Schiffer, CA
Miller, K
Larson, RA
Amrein, PC
Antin, JH
Zani, VJ
Stone, RM
Citation: Ca. Schiffer et al., A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia, BLOOD, 95(8), 2000, pp. 2530-2535
Authors:
Tallman, MS
Andersen, JW
Schiffer, CA
Appelbaum, FR
Feusner, JH
Ogden, A
Shepherd, L
Rowe, JM
Francois, C
Larson, RS
Wiernik, PH
Citation: Ms. Tallman et al., Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome, BLOOD, 95(1), 2000, pp. 90-95
Authors:
Schiffer, CA
van Gunsteren, WF
Citation: Ca. Schiffer et Wf. Van Gunsteren, Accessibility and order of water sites in and around proteins: A crystallographic time-averaging study, PROTEINS, 36(4), 1999, pp. 501-511
Authors:
Lee, EJ
George, SL
Caligiuri, M
Szatrowski, TP
Powell, BL
Lemke, S
Dodge, RK
Smith, R
Baer, M
Schiffer, CA
Citation: Ej. Lee et al., Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previouslyuntreated patients 60 years of age or older with acute myeloid leukemia: Results of cancer and leukemia group B study 9420, J CL ONCOL, 17(9), 1999, pp. 2831-2839
Authors:
Byrd, JC
Dodge, RK
Carroll, A
Baer, MR
Edwards, C
Stamberg, J
Qumsiyeh, M
Moore, JO
Mayer, RJ
Davey, F
Schiffer, CA
Bloomfield, CD
Citation: Jc. Byrd et al., Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered, J CL ONCOL, 17(12), 1999, pp. 3767-3775
Authors:
Gale, RP
Park, RE
Dubois, RW
Herzig, GP
Hocking, WG
Horowitz, MM
Keating, A
Kempin, S
Linker, CA
Schiffer, CA
Wiernik, PH
Weisdorf, DJ
Rai, KR
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase, LEUK RES, 23(9), 1999, pp. 817-826
Authors:
Gale, RP
Park, RE
Dubois, RW
Herzig, GP
Hocking, WG
Horowitz, MM
Keating, A
Kempin, S
Linker, CA
Schiffer, CA
Wiernik, PH
Weisdorf, DJ
Rai, KR
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission, LEUK RES, 23(8), 1999, pp. 709-718